Nicholas Company, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Nicholas Company, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $7.26 Million - $9.48 Million	-14,725 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $410,139 - $603,204	-1,220 Reduced 7.65%	14,725 $7.19 Million
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $22,470 - $31,111	-75 Reduced 0.47%	15,945 $4.99 Million
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $359,057 - $424,185	-965 Reduced 5.68%	16,020 $6.58 Million
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $21.5 Million - $26.1 Million	-75,595 Reduced 81.65%	16,985 $5.86 Million

Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $50,531 - $63,004	-160 Reduced 0.17%	92,580 $31.9 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $5.72 Million - $7.5 Million	15,955 Added 20.78%	92,740 $34.9 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $6.08 Million - $7.11 Million	14,105 Added 22.5%	76,785 $34.3 Million
Q2 2017 Aug 11, 2017	BUY	N/A	62,680	62,680 $30.8 Million

1,427

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $111B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Nicholas Company, Inc. with notifications on news.